PHARMGEORGIA
PHARMGEORGIA plans to construct a middle-scale pharmaceutical factory equipped with GMP standard equipment and technological facility.
Phramgeorgia plans to produce and sell for wholesale markets infusion / sterile solutions.
PHARMGEORGIA will provide primary and secondary packaging and sale for the wholesale market following infusion / sterile solutions :
- Natrium chloride 0.9 % 250 and 500 ml.
- Glucose 3 % 250-500 ml.
- Ringer 500 ml.
- Ringer lactate 500 ml.
- Metronidazole 0.5 % 100 ml.
- Levofloxacin 0.5 % 100 ml .
- Amino carbon acid 0..5 % 100 ml.
- Mannitol 10 % 500 ml.
- Moxifloxacin 10 # 250 ml .
- Paracetamol 1 % 100 ml.
SME’s Valuation Service
we determined the Enterprise Value ( EV ) of PHARMGEORGIA based on the following valuation methods :
- DCF – Discounted Cash Flow Method
- Comparable Companies Analysis Method
- Precedent Transactions Analysis Method
SME’s Business Plan Development
We created a business development plan for PHARMGEORGIA to raise 10 million GEL investments from pharmaceutical sector strategic investors.
The business development plan includes :
- Market research of the pharmaceutical sector.
- Planning pharmaceutical products selling prices and quantity for the wholesale market.
- Planning investment amount needed to construct a pharmaceutical factory.
- Financial modeling with sensitivity analysis.
- Investor agreement and equity stake allocation.
- IRR and Cash On Cash multiple analysis for investors.
.png){kind=small}